U.S. Health Secretary Robert F. Kennedy Jr. is pulling the plug on $500 million in federal funding for mRNA vaccine development, affecting 22 major projects—including those by Pfizer and Moderna.

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market braces for another day of earnings and Trump tariff news.